OPTYX study shows many patients with advanced prostate cancer preferred oral relugolix over injectables for androgen deprivation therapy.

The latest figures on prostate cancer are shocking: it has officially overtaken breast cancer as the most commonly diagnosed ...

After a change in screening guidelines, the incidence increased across the state, surpassing the national trend. A new study ...

SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a radiotherapy-based strategy compared with a radical prostatectomy ...

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

One type of cancer is on the rise in California. Experts at UCSF are finding higher rates of advanced prostate cancer, which ...

As the world marks the International Childhood Cancer Day (ICCD) today, childhood cancer survivors, families, and experts have called on the federal ...

Iowa has the fastest-growing rate of new cancers and ranks second-highest in cancer rates compared to other states, according to the Iowa Cancer Registry.

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

Importantly, rates of thyroid cancer mortality and metastasis at diagnosis over the study period remained ... represents overdiagnosis, since those age groups are most likely to have higher ...

At the beginning of 2024, when I moved to London, and started a new job, I was excited for the future. Then everything changed. A few months into my new life, I was diagnosed with cancer.